Citation Impact
Citing Papers
Zygomycetes in Human Disease
2000 Standout
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
2005 Standout
Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance
2003 Standout
A target selection of somatic hypermutations is regulated similarly between T and B cells upon activation-induced cytidine deaminase expression
2005 StandoutNobel
Basal Cell Carcinomas in Mice Overexpressing Sonic Hedgehog
1997 StandoutScience
Comprehensive molecular portraits of human breast tumours
2012 StandoutNature
The promise and challenge of therapeutic genome editing
2020 StandoutNatureNobel
Southwestern Internal Medicine Conference: Clinical Use of Hematopoietic Growth Factors
1993
Quality of Life and Satisfaction with Outcome among Prostate-Cancer Survivors
2008 Standout
Multifunctional Lipid/Quantum Dot Hybrid Nanocontainers for Controlled Targeting of Live Cells
2006 StandoutNobel
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
2008 StandoutNature
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
2010 Standout
Chronic myelogenous leukemia in nonlymphoid blastic phase
1999
AKT/PKB Signaling: Navigating Downstream
2007 Standout
Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous Leukemia
2002 Standout
Systemic administration of doxorubicin-containing liposomes in cancer patients: a phase I study
1989
A cell initiating human acute myeloid leukaemia after transplantation into SCID mice
1994 StandoutNature
Serum CA19-9 response as a surrogate for clinical outcome in patients receiving fixed-dose rate gemcitabine for advanced pancreatic cancer
2005
Nucleotide excision repair: From E. coli to man
1999 StandoutNobel
Mismatch repair and nucleotide excision repair proteins cooperate in the recognition of DNA interstrand crosslinks
2009 StandoutNobel
Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia
2001 Standout
Paclitaxel (Taxol)
1995 Standout
Emerging oral therapies for multiple sclerosis
2007
Bcr–Abl variants: biological and clinical aspects
2002
The multifaceted roles of fatty acid synthesis in cancer
2016
Phase II evaluation of docetaxel plus one‐day oral estramustine phosphate in the treatment of patients with androgen independent prostate carcinoma
2002
Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies.
1998
Targeting of Liposomes to Tumor Cells in Vivoa
1987
CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma
2002 Standout
Delivery technologies for cancer immunotherapy
2019 Standout
Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer
2004 Standout
The accumulation of drugs within large unilamellar vesicles exhibiting a proton gradient: a survey
1990
Immunity, Inflammation, and Cancer
2010 Standout
Drug Delivery to the Central Nervous System: General Principles and Relevance to Therapy for Infections of the Central Nervous System
1989
Infectious and immunosuppressive complications of purine analog therapy.
1995
Hematopoietic Stem-Cell Transplantation
2006 Standout
Engineering liposomes for drug delivery: progress and problems
1995
Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia Chromosome
2001 Standout
Proteomics: the first decade and beyond
2003
New Spectrum of Fungal Infections in Patients with Cancer
1989
Therapy of lymphoid and undifferentiated chronic myelogenous leukemia in blast crisis with continuous vincristine and adriamycin infusions plus high-dose decadron
1987
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
2010 Standout
Genomic Aberrations and Survival in Chronic Lymphocytic Leukemia
2000 Standout
Pancreatic Cancer
2010 Standout
Molecular Genetic Pathways as Therapeutic Targets in Acute Myeloid Leukemia
2008
Docetaxel and Estramustine Compared with Mitoxantrone and Prednisone for Advanced Refractory Prostate Cancer
2004 Standout
Antifungal and Surgical Treatment of Invasive Aspergillosis: Review of 2,121 Published Cases
1990 Standout
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
2015 Standout
Liposomal drug delivery systems: From concept to clinical applications
2012 Standout
Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
2014 Standout
Protein therapeutics: a summary and pharmacological classification
2007 Standout
The impact of docetaxel, estramustine, and low dose hydrocortisone on the quality of life of men with hormone refractory prostate cancer and their partners: A feasibility study
2001
Three-hour paclitaxel infusion in patients with refractory and relapsed non-Hodgkin's lymphoma.
1995
A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera
2005 StandoutNature
mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways
2004
Synthesis of Heterobifunctional Protein Fusions Using Copper‐Free Click Chemistry and the Aldehyde Tag
2012 StandoutNobel
A Gain-of-Function Mutation of JAK2 in Myeloproliferative Disorders
2005 Standout
MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification
2008 Standout
The cancer genome
2009 StandoutNature
Chronic Lymphocytic Leukemia
1995
Peripheral T- cell lymphomas: diagnosis and management
2003
β-Arrestin2 mediates the initiation and progression of myeloid leukemia
2012 StandoutNobel
Hepatic injury after nonmyeloablative conditioning followed by allogeneic hematopoietic cell transplantation: a study of 193 patients
2003
Successful treatment of invasive aspergillosis in a heart transplant patient.
1985
Systemic aspergillosis as cause of myocardial infarction
1986
Alpha Interferon for Induction of Remission in Hairy-Cell Leukemia
1984
Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes
2002 StandoutScience
Rhinocerebral Mucormycosis in Renal Transplant Recipients: Report of Three Cases and Review of the Literature
1986
A retrospective clinical comparison between antifungal treatment with liposomal amphotericin B (AmBisome) and conventional amphotericin B in transplant recipients
1992
Control of programmed cell death in normal and leukemic cells: new implications for therapy
1993
Zygomycetes in Human Disease
2000 Standout
Apoptosis in the Pathogenesis and Treatment of Disease
1995 StandoutScience
Flow cytometry in clinical cancer research.
1983
Functional Role of Type I and Type II Interferons in Antiviral Defense
1994 StandoutScience
Targeting Oncogenes to Improve Breast Cancer Chemotherapy
2006
Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy.
1991
Site-specific chemical modification of recombinant proteins produced in mammalian cells by using the genetically encoded aldehyde tag
2009 StandoutNobel
Clofarabine, a novel nucleoside analog, is active in pediatric patients with advanced leukemia
2003
Hematologic Remission and Cytogenetic Improvement Induced by Recombinant Human Interferon AlphaAin Chronic Myelogenous Leukemia
1986
Human TKTL1 implies greater neurogenesis in frontal neocortex of modern humans than Neanderthals
2022 StandoutScienceNobel
Conditioning with fludarabine and targeted busulfan for transplantation of allogeneic hematopoietic stem cells
2003
Treatment of Philadelphia Chromosome-Positive Early Chronic Phase Chronic Myelogenous Leukemia With Daily Doses of Interferon Alpha and Low-Dose Cytarabine
1999
Drug Delivery Systems: Entering the Mainstream
2004 StandoutScience
IDEC-C2B8 (Rituximab) Anti-CD20 Monoclonal Antibody Therapy in Patients With Relapsed Low-Grade Non-Hodgkin's Lymphoma
1997
An evidence-based analysis of the effect of busulfan, hydroxyurea, interferon, and allogeneic bone marrow transplantation in treating the chronic phase of chronic myeloid leukemia: developed for the American Society of Hematology.
1999
Polycythemia vera: myths, mechanisms, and management
2002
Protection of CLL B cells by a follicular dendritic cell line is dependent on induction of Mcl-1
2002
Homoharringtonine and Low-Dose Cytarabine in the Management of Late Chronic-Phase Chronic Myelogenous Leukemia
2000
Hematopoietic growth factors and their receptors in acute leukemia
1993
Liposomes in treatment of infectious diseases
1987
Treatment of invasive aspergillus sinusitis with liposomal‐amphotericin B
1987
Cytokine therapeutics: lessons from interferonalpha.
1994
Randomized Phase II Comparison of Dose-Intense Gemcitabine: Thirty-Minute Infusion and Fixed Dose Rate Infusion in Patients With Pancreatic Adenocarcinoma
2003
Phase II Study of Docetaxel, Estramustine, and Low-Dose Hydrocortisone in Men With Hormone-Refractory Prostate Cancer: A Final Report of CALGB 9780
2001
Liposomes as carriers of antimicrobial agents
1987
Liposomal Amphotericin B in the Treatment of Fungal Infections
1986
Rational Design of Bisphosphonate Lipid-like Materials for mRNA Delivery to the Bone Microenvironment
2022 StandoutNobel
World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues: Report of the Clinical Advisory Committee Meeting—Airlie House, Virginia, November 1997
1999 Standout
Effect of lipid composition and liposome size on toxicity and in vitro fungicidal activity of liposome-intercalated amphotericin B
1987
Ibritumomab tiuxetan radioimmunotherapy for patients with relapsed or refractory non-Hodgkin lymphoma and mild thrombocytopenia: a phase II multicenter trial
2002
Fludarabine and cyclophosphamide with filgrastim support in patients with previously untreated indolent lymphoid malignancies
2000
Chronic myelogenous leukemia: a concise update
1993
Molecular Mechanisms of Mammalian DNA Repair and the DNA Damage Checkpoints
2004 StandoutNobel
In Vivo Protein Transduction: Delivery of a Biologically Active Protein into the Mouse
1999 StandoutScience
Chronic Myelogenous Leukemia: Biology and Therapy
1999
Works of M Keating being referenced
Richter's syndrome: a report on 39 patients.
1993
Phase I study of the combination of fludarabine, mitoxantrone, and dexamethasone in low-grade lymphoma.
1994
Prognostic value of plasma interleukin‐6 levels in patients with chronic lymphocytic leukemia
2002
Elimination of chronic lymphocytic leukemia cells in stromal microenvironment by targeting CPT with an antiangina drug perhexiline
2016
Treatment of advanced stages of Philadelphia chromosome-positive chronic myelogenous leukemia with interferon-alpha and low-dose cytarabine.
1992
Fludarabine potentiates metabolism of cytarabine in patients with acute myelogenous leukemia during therapy.
1993
Fludarabine, mitoxantrone, and dexamethasone: an effective new regimen for indolent lymphoma.
1996
Treatment of chronic myelogenous leukemia in accelerated and blastic phases with daunorubicin, high-dose cytarabine, and granulocyte-macrophage colony-stimulating factor.
1992
Primary therapy of Waldenström's macroglobulinemia with 2-chlorodeoxyadenosine.
1994
Phase II trial of fludarabine phosphate in lymphoma: an effective new agent in low-grade lymphoma.
1992
Pharmacologically directed design of the dose rate and schedule of 2',2'-difluorodeoxycytidine (Gemcitabine) administration in leukemia.
1990
Homoharringtonine therapy induces responses in patients with chronic myelogenous leukemia in late chronic phase
1995
Chronic Lymphoproliferative Disorders
2008
High-dose cytosine arabinoside: treatment and cellular pharmacology of chronic myelogenous leukemia blast crisis.
1986
Effects of signal transduction inhibitor 571 in acute myelogenous leukemia cells.
2001
Suppression of clonal evolution in two chronic myelogenous leukaemia patients treated with leucocyte interferon
1985
Treatment of hairy cell leukemia with recombinant alpha-interferon
1986
Quantitative cytology in leukemia research.
1983
Liposomal Amphotericin B for the Treatment of Systemic Fungal Infections in Patients with Cancer: A Preliminary Study
1985
A phase II trial of docetaxel (Taxotere) in hormone-refractory prostate cancer: correlation of antitumor effect to phosphorylation of Bcl-2.
1999
Fludarabine triphosphate inhibits nucleotide excision repair of cisplatin-induced DNA adducts in vitro.
1997
Hairy cell leukemia: Clinical effects of the methanol extraction residue (MER) of BCG, lithium carbonate and mononuclear cell-enriched leukocyte transfusions
1981
Treatment of newly diagnosed acute myelogenous leukemia with granulocyte-macrophage colony-stimulating factor (GM-CSF) before and during continuous-infusion high-dose ara-C + daunorubicin: comparison to patients treated without GM-CSF
1992
Treatment of hairy cell leukemia with recombinant alpha-interferon
1986